Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started
Arrowpoint Asset Management increased stake in 2U, Inc.
Published Apr 12, 2021 04:43PM ET
Updated Apr 12, 2021 05:00PM ET
© Reuters. Arrowpoint Asset Management increased stake in 2U, Inc.
On the 31st of March, Arrowpoint Asset Management bought 2.3 million 2U, Inc. (NASDAQ:TWOU) shares for $88 million at an average price of $38.23 per share. Shares of 2U, Inc. are up 0.37% since the transaction.
Arrowpoint Asset Management's holding in 2U, Inc. increased to about 7.5 million shares with the purchase.
Arrowpoint Asset Management first bought 2U, Inc. stock in the second quarter of 2014. Arrowpoint Asset Management also owns TriNet Group, Inc. (NYSE:TNET), Grand Canyon Education, Inc. (NASDAQ:LOPE) and Altice USA Inc A (ATUS). 2U, Inc. is its number one position by number of shares and market value among consumer services stocks.
Other investors who also added to their 2U, Inc. shares include California State Teachers Retirement System, Gilder Gagnon Howe & Co., and the T. Rowe Price Equity Income Fund. In contrast, Citigroup (NYSE:C), Westfield Capital Management, and Private Capital Group reduced TWOU shares, while Carmignac Gestion sold all their TWOU shares.
Arrowpoint Asset Management has also recently reduced their share in TriNet Group, Inc. The total value of the shares sold is estimated at around $41 million.
Arrowpoint Asset Management also sold all their shares in Liquidia Corporation (LQDA) and BioTelemetry Inc. (NASDAQ:BEAT). These assets constituted 2% of their pre-sale portfolio. Arrowpoint Asset Management also reduced their share in Clean Harbors, Inc. (NYSE:CLH), Graham Corporation (NYSE:GHM), Forward Air Corporation (NASDAQ:FWRD), Albireo Pharma, Inc. (NASDAQ:ALBO), Evolution Petroleum Corporation (NYSE:EPM), Hudson (NYSE:HUD) Technologies, Inc. (HDSN), WisdomTree Investments Inc (NASDAQ:WETF), Heritage-Crystal Clean, Inc. (NASDAQ:HCCI), MEDNAX Inc. (MD), Asure Software Inc (NASDAQ:ASUR), Cooper-Standard Holdings Inc. (NYSE:CPS), RigNet, Inc. (RNET), Shutterstock , Inc. (NYSE:SSTK), Benefitfocus, Inc. (BNFT), Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA), Xeris Pharmaceuticals , Inc. (NASDAQ:XERS), TCR2 Therapeutics Inc . (NASDAQ:TCRR) and Lyra Therapeutics, Inc. (LYRA). The total value of the shares sold is estimated at around $399 million.
In addition, Arrowpoint Asset Management established new holdings in Jaws Acquisition Corp. (JWS) and TS Innovation Acquisitions Corp (TSIAU). Arrowpoint Asset Management also increased their share in Belden Inc (NYSE:BDC), j2 Global, Inc. (JCOM), Merit Medical Systems , Inc. (NASDAQ:MMSI), Sally Beauty (NYSE:SBH), Skechers USA Inc (NYSE:SKX), Tennant Company (TNC), ABM Industries Inc (NYSE:ABM), Heartland Express , Inc. (NASDAQ:HTLD), Heron Therapeutics, Inc. (NASDAQ:HRTX), Axogen Inc. (AXGN), Clarus Corporation (NASDAQ:CLAR), Ontrak, Inc. (OTRK), ChannelAdvisor Corporation (NYSE:ECOM), Revance Therapeutics Inc (NASDAQ:RVNC), Viking Therapeutics Inc (NASDAQ:VKTX), Switch Inc (NYSE:SWCH), PlayAGS, Inc. (AGS), Pluralsight Inc (NASDAQ:PS) and Matson , Inc. (NYSE:MATX). The total value of the shares bought is estimated at around $285 million.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.